A novel class of tubulin inhibitors that exhibit potent antiproliferation and in vitro vessel-disrupting activity

Author： Meng Fanying   Cai Xiaohong   Duan Jianxin   Matteucci Mark   Hart Charles  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.61, Iss.6, 2008-05, pp. : 953-963

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo

By Ozawa  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2275-2282

Elsevier

Access to resources Recommend Favorite

In vitro and in vivo activity of LS 4477 and LS 4559, novel analogues of the tubulin binder estramustine

By Nicholson K.M.   Phillips R.M.   Shnyder S.D.   Bibby M.C.  

European Journal of Cancer, Vol. 38, Iss. 1, 2002-01 ,pp. : 194-204

Elsevier

Access to resources Recommend Favorite

Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells

By                

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1824-1832

Spandidos Publications

Access to resources Recommend Favorite

Tubulin Inhibitors: A Patent Survey

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 2, 2014-05 ,pp. : 176-220

Bentham Science Publishers

Access to resources Recommend Favorite

Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 4, 2017-04 ,pp. : 552-565

Bentham Science Publishers

Access to resources Recommend Favorite